Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 2, Number 3, July 2004

Review article

Favourites:
ADD

Reactive Oxygen Species, Vascular Disease and Cardiovascular Surgery
pp. 229-236(8)
Authors: Jeremy, Jamie Y.; Shukla, Nilima; Muzaffar, Saima; Handley, Alexandra; Angelini, Gianni D.

Favourites:
ADD

Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
pp. 237-248(12)
Authors: Casis, O.; Echevarria, E.

Favourites:
ADD

Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis
pp. 249-258(10)
Authors: Ihling, C.; Bohrmann, B.; Schaefer, H. E.; Technau-Ihling, K.; Loeffler, B. M.

Favourites:
ADD

Recent Progress on Tumor Missile Therapy and Tumor Vascular Targeting Therapy as a New Approach
pp. 259-270(12)
Authors: Yoshioka, Yasuo; Tsutsumi, Yasuo; Nakagawa, Shinsaku; Mayumi, Tadanori

Favourites:
ADD

Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
pp. 281-299(19)
Authors: Muro, Silvia; Koval, Michael; Muzykantov, Vladimir

Favourites:
ADD

Update in the Management of Diastolic Heart Failure
pp. 301-308(8)
Authors: Yu, Cheuk-Man; Sanderson, John E.

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more